BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6419316)

  • 1. Pathogenesis of Pseudomonas aeruginosa ocular diseases.
    Kreger AS
    Rev Infect Dis; 1983; 5 Suppl 5():S931-5. PubMed ID: 6419316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence of Pseudomonas aeruginosa to the injured cornea: a step in the pathogenesis of corneal infections.
    Ramphal R; McNiece MT; Polack FM
    Ann Ophthalmol; 1981 Apr; 13(4):421-5. PubMed ID: 6787968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis.
    Masinick SA; Montgomery CP; Montgomery PC; Hazlett LD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):910-8. PubMed ID: 9112987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival.
    Mochizuki Y; Suzuki T; Oka N; Zhang Y; Hayashi Y; Hayashi N; Gotoh N; Ohashi Y
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):240-6. PubMed ID: 24255043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model.
    Cole N; Willcox MD; Fleiszig SM; Stapleton F; Bao B; Tout S; Husband A
    Curr Eye Res; 1998 Jul; 17(7):730-5. PubMed ID: 9678419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Pseudomonas aeruginosa keratitis from extended wear of soft contact lenses.
    Koch JM; Refojo MF; Hanninen LA; Leong FL; Kenyon KR
    Arch Ophthalmol; 1990 Oct; 108(10):1453-9. PubMed ID: 2121123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia increases corneal cell expression of CFTR leading to increased Pseudomonas aeruginosa binding, internalization, and initiation of inflammation.
    Zaidi T; Mowrey-McKee M; Pier GB
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4066-74. PubMed ID: 15505057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lecithin-bound superoxide dismutase in the prevention of neutrophil-induced damage of corneal tissue.
    Matsumoto K; Shimmura S; Goto E; Saito K; Takeuchi T; Miyajima S; Negi A; Tsubota K
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):30-5. PubMed ID: 9430542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic considerations in the treatment of bacterial keratitis.
    Callegan MC; O'Callaghan RJ; Hill JM
    Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycan involvement in the adhesion of Pseudomonas aeruginosa to tears.
    Kautto L; Nguyen-Khuong T; Everest-Dass A; Leong A; Zhao Z; Willcox MDP; Packer NH; Peterson R
    Exp Eye Res; 2016 Apr; 145():278-288. PubMed ID: 26851486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies provide protection against ocular Pseudomonas aeruginosa infection.
    Moon MM; Hazlett LD; Hancock RE; Berk RS; Barrett R
    Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1277-84. PubMed ID: 2843483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit corneal damage produced by Pseudomonas aeruginosa infection.
    Gray LD; Kreger AS
    Infect Immun; 1975 Aug; 12(2):419-32. PubMed ID: 169202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats.
    Thakur A; Kyd J; Xue M; Willcox MD; Cripps A
    Infect Immun; 2001 May; 69(5):3295-304. PubMed ID: 11292752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adherence of Pseudomonas aeruginosa to the rabbit corneal epithelium].
    Tazawa H
    Nippon Ganka Gakkai Zasshi; 1990 Mar; 94(3):269-76. PubMed ID: 2118720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
    Mannis MJ
    Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal Biofilms: From Planktonic to Microcolony Formation in an Experimental Keratitis Infection with Pseudomonas Aeruginosa.
    Saraswathi P; Beuerman RW
    Ocul Surf; 2015 Oct; 13(4):331-45. PubMed ID: 26220579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.
    Tajima K; Miyake T; Koike N; Hattori T; Kumakura S; Yamaguchi T; Matsumoto T; Fujita K; Kuroda M; Ito N; Goto H
    J Infect Chemother; 2014 Jun; 20(6):343-9. PubMed ID: 24726376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review.
    Willcox MD
    Optom Vis Sci; 2007 Apr; 84(4):273-8. PubMed ID: 17435510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS
    Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.